Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Syed Athar

Interventional Cardiology Loma Linda, CA Medical Doctor

NPI 1508038597 CMS profile 158966

11201 Benton St, Loma Linda, CA 92357

Open in the dashboard

General payments

$13,673

58 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Syed Athar of Loma Linda, CA is reported in the CMS Open Payments database as having received $13,673 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,304 13
2024 General $697 11
2023 General $238 6
2022 General $1,599 21
2021 General $8,553 2
2020 General $1,267 4
2019 General $15 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Syed Athar
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Syed Athar were reported at $1,304. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Syed Athar Interventional Cardiology median Middle half National median
2019 $15 $1,097 $329–$3,048 $163
2020 $1,267 $473 $161–$1,480 $114
2021 $8,553 $677 $233–$1,827 $132
2022 $1,599 $978 $333–$2,724 $149
2023 $238 $1,136 $382–$2,986 $160
2024 $697 $1,181 $395–$3,326 $164
2025 $1,304 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $10,343 28 payments
  2. Boston Scientific Corporation $1,334 10 payments
  3. Cardiovascular Systems Inc. $1,255 3 payments
  4. Abbott Laboratories $623 13 payments
  5. Philips Electronics North America Corporation $64 1 payment
  6. Roche Diagnostics Corporation $26 1 payment
  7. Lantheus Medical Imaging, Inc. $15 1 payment
  8. Ge Healthcare $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $10,520 12 payments
  2. Food and Beverage $2,072 45 payments
  3. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,080 1 payment
Products named General payments · program years 2019–2025
  1. Resolute $8,489 1 payment
  2. RESOLUTE ONYX $1,683 22 payments
  3. Coronary Orbital Atherectomy System $1,255 3 payments
  4. General - Vascular Access $765 3 payments
  5. ULTREON $357 2 payments
  6. DRAGONFLY OPSTAR $177 4 payments
  7. AVVIGO Guidance System $150 1 payment
  8. EkoSonic $142 1 payment
  9. ROTAPRO $136 4 payments
  10. ONYX FRONTIER $76 2 payments
  11. Other $265 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record